About 9 000 reports

The APAC point of care diagnostics market is expected to grow from US$ 6,548.48 million in 2021 to US$ 15,641.78 million by 2028; it is estimated to grow at a CAGR of 13.2% from 2021 to 2028. The growing use of home-based poc devices is expected to surge the market.The increasing awareness about point of care testing is bringing the...

  • Point Of Care Testing
  • Diagnostics
  • Infectious Disease
  • APAC
  • Diabetes Prevalence
  • Cancer Incidence

The Europe point of care diagnostics market is expected to grow from US$ 8,948.81 million in 2021 to US$ 20,207.60 million by 2028; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028. Rising prevalence of infectious diseases is expected to fuel the market growth.Point-of-care testing (POCT) plays a critical role in diagnosis,...

  • Point Of Care Testing
  • Diagnostics
  • Infectious Disease
  • Europe
  • Drug Approval
  • Laboratory Revenue

China’s demand for Anti-infectious Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Infectious Disease
  • China
  • Industrial Production
  • Labour Force

The global infectious disease diagnostics market size is projected to reach USD 39.8billion by 2026 from USD 28.1billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift...

  • Infectious Disease
  • Diagnostics
  • World
  • United States
  • Europe
  • APAC
  • North America
  • Health Expenditure
  • Drug Approval

The Infectious Disease Diagnostics Market was estimated to be USD 38,480.89 million in 2021 and is poised to grow at a CAGR of 3.79% by 2027 to reach USD 50,345.74 million. The COVID-19 pandemic has significantly impacted the infectious disease diagnostics market. Increasing incidences of infection in COVID-19 patients is anticipated...

  • Infectious Disease
  • Diagnostics
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

Point-of-Care (POC) Molecular testing enables physicians to improve the standard of care by combining quick diagnosis with treatment decision in the first visit by the patient instead of hours and days to have the test results. This would help prescribe treatment in the first instance without having to wait for final results. In past decades,...

  • Molecular Diagnostics
  • Infectious Disease
  • World
  • APAC
  • Cancer Incidence
  • Elderly Population

Pandemic Influenza - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Pandemic Influenza - Global Clinical Trials Review, H2, 2021" provides an overview of Pandemic Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Pandemic...

  • Influenza
  • Clinical Trial
  • World
  • Medical Technology Density
  • Hospital Admission

Dengue Fever - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Dengue Fever - Global Clinical Trials Review, H2, 2021" provides an overview of Dengue Fever Clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever. Report...

  • Clinical Trial
  • Infectious Disease
  • World

Europe Infectious Disease Diagnostics Market to Reach $7,900.4 Million by 2031 Market Report Coverage - Europe Infectious Disease Diagnostics Market Segmentation • Product (system, kits and reagents, and software) • Testing location (laboratory testing and point-of-care testing) •...

  • Infectious Disease
  • Diagnostics
  • Europe

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Infectious Disease Diagnostics Market Report The infectious disease diagnostics market by revenue is expected to grow at a CAGR of over 7% during the period 2019–2025. The global infectious disease diagnostics market, which is one of...

  • Infectious Disease
  • Diagnostics
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the Veterinary Infectious Disease...

  • Diagnostics
  • Infectious Disease
  • World
  • Latin America

Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021" provides an overview of Epstein-Barr Virus (HHV-4) Infections Clinical trials scenario. This report provides...

  • Infectious Disease
  • Clinical Trial
  • World
  • Stem Cell Transplantation

The veterinary infectious disease diagnostics market is expected to reach USD 2.6 billion by 2026 from an estimated USD 1.7 billion in 2021, at a CAGR of 9.0%. The major factors driving the growth of the veterinary infectious disease diagnostics include the growing demand for rapid tests, rising technological advancements, growth in companion...

  • Infectious Disease
  • Diagnostics
  • World
  • United States
  • Dairy Products Consumption

Tetanus Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Tetanus Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Tetanus Clinical trials scenario. This report provides top line data relating to the clinical trials on Tetanus . Report includes...

  • Infectious Disease
  • Clinical Trial
  • World
  • APAC
  • G7
  • Vaccination Coverage

Diphtheria Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Diphtheria Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Diphtheria Clinical trials scenario. This report provides top line data relating to the clinical trials on Diphtheria....

  • Infectious Disease
  • Clinical Trial
  • World
  • G7
  • APAC
  • Vaccination Coverage

Infectious Disease Diagnostics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Infectious Disease Diagnostics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Infectious Disease Diagnostics types,...

  • Diagnostics
  • Infectious Disease
  • World

Infectious Disease Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Infectious Disease Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Infectious Disease Drugs types, applications. Further,...

  • Infectious Disease
  • World

Veterinary Infectious Disease Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Veterinary Infectious Disease Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Veterinary Infectious...

  • Infectious Disease
  • World

Point-of-Care Infectious Disease Diagnostics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Point-of-Care Infectious Disease Diagnostics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Point-of-Care...

  • Infectious Disease
  • Diagnostics
  • World

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Technology (PCR, ISH, INAAT), By End-use, By Application, By Region, And Segment Forecasts, 2021 - 2028 Infectious Disease Molecular Diagnostics Market Growth & Trends The...

  • Molecular Diagnostics
  • Infectious Disease
  • World
  • APAC

The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis...

  • Healthcare
  • Infectious Disease
  • Cancer
  • World
  • North America
  • APAC
  • Cancer Incidence
  • Health Expenditure

Global Infectious Disease Testing Market, By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others), By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections...

  • Infectious Disease
  • World
  • Infectious Disease Incidence

Herpes Zoster (Shingles) Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Herpes Zoster (Shingles) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Herpes Zoster (Shingles) Clinical trials scenario.This report provides top line data relating...

  • Infectious Disease
  • Clinical Trial
  • World
  • G7
  • APAC

The injectable drugs market is expected to register a CAGR of nearly 11.1 % during the forecast period. Currently, big pharma giants are seeking collaborations and approvals to come up with a vaccine in the market space, to prevent the spread of COVID-19 as soon as possible. These vaccines are majorly given in the injectable form,...

  • Pharmaceutical
  • Infectious Disease
  • World
  • Drug Approval
  • Chronic Disease Prevalence

Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections – Drugs In Development, 2021, provides an overview of the Zika Virus Infections (Infectious Disease) pipeline landscape. Zika...

  • Infectious Disease
  • Drug Development
  • World
  • United States
  • Asia
  • Japan
  • India
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

Global Infectious Diseases Partnering 2015 to 2022 provides the full collection of Infectious Diseases disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Trends in Infectious Diseases partnering deals Financial deal terms for headline, upfront and royalty by stage of development Infectious...

  • Infectious Disease
  • World

Infectious Disease Diagnostics Market Report Overview Infectious Disease Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Infectious Disease Diagnostics market types and applications. It is a focused study on Infectious Disease...

  • Diagnostics
  • Infectious Disease
  • World
  • Health Provider Density

Infectious Disease Drugs Market Report Overview Infectious Disease Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Infectious Disease Drugs market types and applications. It is a focused study on Infectious Disease Drugs market...

  • Infectious Disease
  • World
  • Health Provider Density

Veterinary Infectious Disease Therapeutics Market Report Overview Veterinary Infectious Disease Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Veterinary Infectious Disease Therapeutics market types and applications. It...

  • Infectious Disease
  • World
  • Health Provider Density

Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hospital Acquired Pneumonia (HAP) - Drugs in Development by Stages, Target, MoA, RoA, Molecule...

  • Infectious Disease
  • Therapy
  • Pharmaceutical
  • World
  • Smoking Prevalence
  • Pharmaceutical Revenue